尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Stover Jack e. Director active across 3 companies, notably Interpace Diagnostics Group, Inc.. Cumulatively, 6 disclosures have been logged. Activity tracked since 12 December 2025. The latest transaction was disclosed on 21 August 2026 (J). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
STOVER JACK E is a declarant linked to Profusa, Inc., where he is Chief Executive Officer, to Traws Pharma, Inc., where he is Director, and to Interpace Diagnostics Group, Inc., where he is Interim President and CEO. He has 6 filings in total, and among the sampled recent filings, the period runs from 2016-02-05 to 2026-09-04, with sum_buy_eur at 0 and sum_sell_eur at 0.